Blunt Roshawn A. 4
4 · Kronos Bio, Inc. · Filed Jun 26, 2023
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
Blunt Roshawn A.
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-22+34,000→ 34,000 totalExercise: $1.48Exp: 2033-06-21→ Common Stock (34,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.